Topline Capital Management, LLC - 25 Sep 2025 SCHEDULE 13G Report for Cytek Biosciences, Inc. Common Stock - $0.001 par value (CTKB)

Filing Manager
Topline Capital Management, LLC
Reporting Manager
Topline Capital Management, LLC
Security
Cytek Biosciences, Inc. Common Stock - $0.001 par value
Symbol
CTKB
Shares outstanding
128M shares
Disclosed Ownership
6.78M shares
Ownership
5.3%
Form type
SCHEDULE 13G
Filing time
17 Nov 2025, 11:44:03 UTC
Date of event
25 Sep 2025
SEC
View on sec.gov

Reporting Managers (3)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Topline Capital Management, LLC 5.3% 6.78M 6.78M 0 /s/ Collin McBirney By: Collin McBirney, Managing Member
Collin McBirney 5.3% 6.78M 0 6.78M /s/ Collin McBirney Collin McBirney
Topline Capital Partners, LP 5.3% 6.78M 6.78M 0 /s/ Collin McBirney By: Topline Capital Management, LLC, the general partner By: Collin McBirney, its Managing Member